SYBX

Synlogic, Inc. - Common Stock (SYBX)

About Synlogic, Inc. - Common Stock (SYBX)

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.

Details

Daily high

$1.27

Daily low

$1.21

Price at open

$1.23

52 Week High

$1.88

52 Week Low

$0.90

Market cap

14.2M

Dividend yield

0.00%

Volume

3,869

Avg. volume

8,870

P/E ratio

10.36

Synlogic, Inc. - Common Stock News